Study of MORF 057 to Evaluate Single and Multi Ascending Doses in Healthy Volunteers
Clinical trial NCT04580745 · COMPLETED
Trial details
- NCT number
- NCT04580745
- Sponsor
- Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-23
- Primary completion
- 2021-03-31
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.